Medetomidine, an α2-adrenergic agonist, activates cardiac vagal nerve through modulation of baroreflex control

Shuji Shimizu, Tsuyoshi Akiyama, Toru Kawada, Yusuke Sata, Masaki Mizuno, Atsunori Kamiya, Toshiaki Shishido, Masashi Inagaki, Mikiyasu Shirai, Shunji Sano, Masaru Sugimachi

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

Background: Although α2-adrenergic agonists have been reported to induce a vagal-dominant condition through suppression of sympathetic nerve activity, there is little direct evidence that they directly increase cardiac vagal nerve activity. Using a cardiac microdialysis technique, we investigated the effects of medetomidine, an α2-adrenergic agonist, on norepinephrine (NE) and acetylcholine (ACh) release from cardiac nerve endings. Methods and Results: A microdialysis probe was implanted into the right atrial wall near the sinoatrial node in anesthetized rabbits and perfused with Ringer's solution containing eserine. Dialysate NE and ACh concentrations were measured using high-performance liquid chromatography. Both 10 and 100 μg/kg of intravenous medetomidine significantly decreased mean blood pressure (BP) and the dialysate NE concentration, but only 100 μg/kg of medetomidine enhanced ACh release. Combined administration of medetomidine and phenylephrine maintained mean BP at baseline level, and augmented the medetomidine-induced ACh release. When we varied the mean BP using intravenous administration of phenylephrine, treatment with medetomidine significantly steepened the slope of the regression line between mean BP and log ACh concentration. Conclusions: Medetomidine increased ACh release from cardiac vagal nerve endings and augmented baroreflex control of vagal nerve activity.

Original languageEnglish
Pages (from-to)152-159
Number of pages8
JournalCirculation Journal
Volume76
Issue number1
DOIs
Publication statusPublished - Jan 2012

Fingerprint

Medetomidine
Adrenergic Agonists
Baroreflex
Acetylcholine
Blood Pressure
Norepinephrine
Nerve Endings
Dialysis Solutions
Microdialysis
Phenylephrine
Physostigmine
Sinoatrial Node
Intravenous Administration
High Pressure Liquid Chromatography
Rabbits

Keywords

  • Acetylcholine
  • Norepinephrine
  • Sinoatrial node
  • Sympathetic nervous system
  • Vagus nerve

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Medetomidine, an α2-adrenergic agonist, activates cardiac vagal nerve through modulation of baroreflex control. / Shimizu, Shuji; Akiyama, Tsuyoshi; Kawada, Toru; Sata, Yusuke; Mizuno, Masaki; Kamiya, Atsunori; Shishido, Toshiaki; Inagaki, Masashi; Shirai, Mikiyasu; Sano, Shunji; Sugimachi, Masaru.

In: Circulation Journal, Vol. 76, No. 1, 01.2012, p. 152-159.

Research output: Contribution to journalArticle

Shimizu, S, Akiyama, T, Kawada, T, Sata, Y, Mizuno, M, Kamiya, A, Shishido, T, Inagaki, M, Shirai, M, Sano, S & Sugimachi, M 2012, 'Medetomidine, an α2-adrenergic agonist, activates cardiac vagal nerve through modulation of baroreflex control', Circulation Journal, vol. 76, no. 1, pp. 152-159. https://doi.org/10.1253/circj.CJ-11-0574
Shimizu, Shuji ; Akiyama, Tsuyoshi ; Kawada, Toru ; Sata, Yusuke ; Mizuno, Masaki ; Kamiya, Atsunori ; Shishido, Toshiaki ; Inagaki, Masashi ; Shirai, Mikiyasu ; Sano, Shunji ; Sugimachi, Masaru. / Medetomidine, an α2-adrenergic agonist, activates cardiac vagal nerve through modulation of baroreflex control. In: Circulation Journal. 2012 ; Vol. 76, No. 1. pp. 152-159.
@article{c132ad714f0a47b28e529c2c46c68233,
title = "Medetomidine, an α2-adrenergic agonist, activates cardiac vagal nerve through modulation of baroreflex control",
abstract = "Background: Although α2-adrenergic agonists have been reported to induce a vagal-dominant condition through suppression of sympathetic nerve activity, there is little direct evidence that they directly increase cardiac vagal nerve activity. Using a cardiac microdialysis technique, we investigated the effects of medetomidine, an α2-adrenergic agonist, on norepinephrine (NE) and acetylcholine (ACh) release from cardiac nerve endings. Methods and Results: A microdialysis probe was implanted into the right atrial wall near the sinoatrial node in anesthetized rabbits and perfused with Ringer's solution containing eserine. Dialysate NE and ACh concentrations were measured using high-performance liquid chromatography. Both 10 and 100 μg/kg of intravenous medetomidine significantly decreased mean blood pressure (BP) and the dialysate NE concentration, but only 100 μg/kg of medetomidine enhanced ACh release. Combined administration of medetomidine and phenylephrine maintained mean BP at baseline level, and augmented the medetomidine-induced ACh release. When we varied the mean BP using intravenous administration of phenylephrine, treatment with medetomidine significantly steepened the slope of the regression line between mean BP and log ACh concentration. Conclusions: Medetomidine increased ACh release from cardiac vagal nerve endings and augmented baroreflex control of vagal nerve activity.",
keywords = "Acetylcholine, Norepinephrine, Sinoatrial node, Sympathetic nervous system, Vagus nerve",
author = "Shuji Shimizu and Tsuyoshi Akiyama and Toru Kawada and Yusuke Sata and Masaki Mizuno and Atsunori Kamiya and Toshiaki Shishido and Masashi Inagaki and Mikiyasu Shirai and Shunji Sano and Masaru Sugimachi",
year = "2012",
month = "1",
doi = "10.1253/circj.CJ-11-0574",
language = "English",
volume = "76",
pages = "152--159",
journal = "Circulation Journal",
issn = "1346-9843",
publisher = "Japanese Circulation Society",
number = "1",

}

TY - JOUR

T1 - Medetomidine, an α2-adrenergic agonist, activates cardiac vagal nerve through modulation of baroreflex control

AU - Shimizu, Shuji

AU - Akiyama, Tsuyoshi

AU - Kawada, Toru

AU - Sata, Yusuke

AU - Mizuno, Masaki

AU - Kamiya, Atsunori

AU - Shishido, Toshiaki

AU - Inagaki, Masashi

AU - Shirai, Mikiyasu

AU - Sano, Shunji

AU - Sugimachi, Masaru

PY - 2012/1

Y1 - 2012/1

N2 - Background: Although α2-adrenergic agonists have been reported to induce a vagal-dominant condition through suppression of sympathetic nerve activity, there is little direct evidence that they directly increase cardiac vagal nerve activity. Using a cardiac microdialysis technique, we investigated the effects of medetomidine, an α2-adrenergic agonist, on norepinephrine (NE) and acetylcholine (ACh) release from cardiac nerve endings. Methods and Results: A microdialysis probe was implanted into the right atrial wall near the sinoatrial node in anesthetized rabbits and perfused with Ringer's solution containing eserine. Dialysate NE and ACh concentrations were measured using high-performance liquid chromatography. Both 10 and 100 μg/kg of intravenous medetomidine significantly decreased mean blood pressure (BP) and the dialysate NE concentration, but only 100 μg/kg of medetomidine enhanced ACh release. Combined administration of medetomidine and phenylephrine maintained mean BP at baseline level, and augmented the medetomidine-induced ACh release. When we varied the mean BP using intravenous administration of phenylephrine, treatment with medetomidine significantly steepened the slope of the regression line between mean BP and log ACh concentration. Conclusions: Medetomidine increased ACh release from cardiac vagal nerve endings and augmented baroreflex control of vagal nerve activity.

AB - Background: Although α2-adrenergic agonists have been reported to induce a vagal-dominant condition through suppression of sympathetic nerve activity, there is little direct evidence that they directly increase cardiac vagal nerve activity. Using a cardiac microdialysis technique, we investigated the effects of medetomidine, an α2-adrenergic agonist, on norepinephrine (NE) and acetylcholine (ACh) release from cardiac nerve endings. Methods and Results: A microdialysis probe was implanted into the right atrial wall near the sinoatrial node in anesthetized rabbits and perfused with Ringer's solution containing eserine. Dialysate NE and ACh concentrations were measured using high-performance liquid chromatography. Both 10 and 100 μg/kg of intravenous medetomidine significantly decreased mean blood pressure (BP) and the dialysate NE concentration, but only 100 μg/kg of medetomidine enhanced ACh release. Combined administration of medetomidine and phenylephrine maintained mean BP at baseline level, and augmented the medetomidine-induced ACh release. When we varied the mean BP using intravenous administration of phenylephrine, treatment with medetomidine significantly steepened the slope of the regression line between mean BP and log ACh concentration. Conclusions: Medetomidine increased ACh release from cardiac vagal nerve endings and augmented baroreflex control of vagal nerve activity.

KW - Acetylcholine

KW - Norepinephrine

KW - Sinoatrial node

KW - Sympathetic nervous system

KW - Vagus nerve

UR - http://www.scopus.com/inward/record.url?scp=84255183862&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84255183862&partnerID=8YFLogxK

U2 - 10.1253/circj.CJ-11-0574

DO - 10.1253/circj.CJ-11-0574

M3 - Article

C2 - 22040937

AN - SCOPUS:84255183862

VL - 76

SP - 152

EP - 159

JO - Circulation Journal

JF - Circulation Journal

SN - 1346-9843

IS - 1

ER -